Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acute Kidney Injury (Phase 3)
Amyotrophic Lateral Sclerosis (Phase 2)
Brain Injuries (Phase 2/Phase 3)
Brain Injuries, Traumatic (Phase 3)
Cataract (Phase 4)
Corneal Diseases (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
HIV Infections (Phase 1)
Keratoconus (Phase 1/Phase 2)
Lacrimal Apparatus Diseases (Phase 1)
Liver Cirrhosis (Phase 2/Phase 3)
Macular Edema (Phase 4)
Motor Neuron Disease (Phase 2)
Uveitis, Anterior (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue